Hormone replacement therapy in postmenopausal women: Carotid intima-media thickness and 3-D volumetric plaque quantification

Maturitas

Volumn 32, Issue 1, 1999, Pages 33-40

  Griewing, B ^a   Römer, Th ^a   Spitzer, C ^a   Ludemann J ^a   Gunther A ^a   Kessler, Ch ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

3 D ultrasound; Carotid atherosclerosis; Duplexsonography; Hormones; Menopause

Indexed keywords

ESTROGEN; GESTAGEN;

ARTICLE; ATHEROSCLEROTIC PLAQUE; COMMON CAROTID ARTERY; DOPPLER FLOWMETRY; DRUG EFFECT; HORMONE SUBSTITUTION; POSTMENOPAUSE; RISK ASSESSMENT; STROKE; THREE DIMENSIONAL IMAGING;

ADULT; ARTERIOSCLEROSIS; CAROTID STENOSIS; CEREBROVASCULAR DISORDERS; CLIMACTERIC; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MIDDLE AGED; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA; ULTRASONOGRAPHY, DOPPLER;

EID: 0041730107     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(99)00014-6     Document Type: Article

References (41)

1. Ross R.K., Paganini-Hill A., Mack T.M., Arthur M., Henderson B.M. Menopausal estrogen therapy and protection from death from ischaemic heart disease. Lancet. 234:1981;856-860.
2. Stampfer M.J., Colditz G.A., Willett W.C. et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. New Engl. J. Med. 325:1991;756-762.
3. Adams M.R., Kaplan J.R., Koritnik D.R., Clarkson T.B. Pregnancy-associated inhibition of coronary artery atherosclerosis in monkeys. Evidence of a relationship with endogenous estrogen. Arteriosclerosis. 7:1987;378-384.
4. Barrett-Connor E., Bush T.L. Estrogen and coronary heart disease in women. J. Am. Med. Assoc. 265:1991;1861-1867.
5. Bush T.L., Barrett-Connor E., Cowan L.D. et al. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 75:1987;1102-1109.
6. Manson J.E. Postmenopausal hormone therapy and atherosclerotic disease. Am. Heart. J. 128:1994;1337-1343.
7. Lindenstrom E., Boysen G., Nyboe J. Lifestyle factors and risk of cerebrovascular disease in women. The Copenhagen City Heart Study. Stroke. 24:1993;1468-1472.
8. Duprez D. Is vascular disease in the female different from men? Int. Angiol. 12:1993;331-334.
9. Lobo R.A. Benefits and risks of estrogen replacement therapy. Am. J. Obstet. Gynecol. 173:1995;982-989.
10. Paganini-Hill A., Ross R.K., Henderson B.E. Postmenopausal oestrogen treatment and stroke: a prospective study. Br. Med. J. 297:1988;519-522.
11. Hunt K., Vessey M., McPherson K. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br. J. Obstet. Gynaecol. 97:1990;1080-1086.
12. Henderson B.E., Paganini-Hill A., Ross R.K. Decreased mortality in users of estrogen replacement therapy. Arch. Intern. Med. 151:1991;75-78.
13. Davis P. Stroke in Women. Curr. Opin. Neurol. 7:1994;36-40.
14. Falkeborn M., Persson I., Terent A., Adami O.H., Lithell H., Bergström H. Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden. Arch. Int. Med. 153:1993;1201-1209.
15. Finucane F.F., Madans J.H., Bush T.L., Wolf P.H., Kleinman J.C. Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. Arch. Int. Med. 153:1993;73-79.
16. Belfort M.A., Saade G.R., Snaber M. et al. Hormonal status affects the reactivity of the cerebral vasculature. Am. J. Obstet. Gynecol. 173:1995;1273-1278.
17. Gangar K.F., Vyas S., Whitehead M.I. et al. Pulsatility index in the internal carotid artery is influenced by transdermal oestradiol and time since menopause. Lancet. 338:1991;839-842.
18. Penoth M., Nencioni T., Gabrielli L., Farina H., Castiglioni E., Polvani F. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy. Am. J. Obstet. Gynecol. 169:1993;1226-1232.
19. Punnonen R.H., Jokela H.A., Dastidar P.S., Nevala M., Laippala P.J. Combined estrogen-progestin replacement therapy prevents atherosclerosis in postmenopausal women. Maturitas. 21:1995;179-187.
20. Manolio T.A., Furberg C.D., Shemanski L. et al. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research Group. Circulation. 88:1993;2163-2171.
21. Howard G., Sharrett A.R., Heiss G. et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke. 9:1993;1204-1297.
22. Howard G., Burke G.L., Evans G.W. et al. Relations of intimal-medial thickness among sites within the carotid artery as evaluated by B-mode ultrasound. Stroke. 8:1994;1581-1587.
23. Baldassarre D., Werba J.P., Tremoli E., Poli A., Pazzucconi F., Sirtori C.R. Common carotid intima-media thickness measurement. A method to improve accuracy and precision. Stroke. 25:1994;1588-1592.
24. Girerd X., Mourad J.J., Acar C. et al. Noninvasive measurement of medium-sized artery intime-media thickness in humans: in vitro validation. J. Vasc. Res. 31:1994;114-120.
25. Griewing B., Schminke U., Morgenstern C., Walker M.L., Kessler Ch. 3-D ultrasound angiography (power mode) for the quantification of carotid artery atherosclerosis. J. Neuroimag. 7:1997;43-48.
26. v. Reutern G.M., v. Büdingen J.H. Ultraschalldiagnostik der Hirnversorgenden Arterien. 1989;Thieme, Stuttgart.
27. Masi A.T., Dugdale M. Cerebrovascular disease associated with the use of oral contraceptives. Ann. Intern. Med. 72:1970;111-121.
28. Bickerstaff E.R. Neurological Complications of Oral Contraceptives. 1975;Clarendon Press, Oxford.
29. Poulter N.R., Chang C.L., Farley T.M.M., Meirik O., Marmot M.G. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet. 348:1996;498-505.
30. Wilson P.W.F., Garrison R.J., Castelli W.P. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. New Engl. J. Med. 17:1985;1038-1043.
31. Dempsey R.J., Diana A.L., Moore R.W. Thickness of carotid artery atherosclerotic plaque and ischemic risk. J. Neurosurg. 27:1990;343-348.
32. Eliasziw M., Rankin R.N., Fox A.J., Haynes R.B., Barnett H.J.M. Accuracy and prognostic consequences of ultrasonography in identifying severe carotid artery stenosis. Stroke. 26:1995;1747-1752.
33. Ianuzzi A., Wilcosky T., Mercuri M., Rubba P., Bryan F.A., Bond M.G. Ultrasonographic correlates of carotid atherosclerosis in transient ischemic attack and stroke. Stroke. 26:1995;614-619.
34. Weinberger J., Ramos L., Ambrose A., Foster V. Morphologic and dynamic changes of atherosclerotic plaque at the carotid artery bifurcation: sequential imaging by real-time B-mode ultrasonography. J. Am. Coll. Cardiol. 12:1988;1515-1524.
35. Delcker A., Diener H.C. Meßparameter zur Quantifizierung beginnender arteriosklerotischer Wandveränderungen der Karotiden. Ultraschall. Klin. Prax. 12:1996;155-161.
36. Williams J.K., Adams M.R., Klopfenstein H.S. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 81:1990;1680-1687.
37. Williams J.K., Adams M.R., Herrington D.M., Clarkson T.B. Effects of short-term estrogen treatment on vascular responses of coronary arteries. J. Am. Coll. Cardiol. 20:1992;452-457.
38. Seeger H., Muck A.O., Lippert T.H. Einfluß von Östradiol und C19- und C21 Gestagenen auf den Calcium-Influx in menschlichen Aortenzellen. J. Menopause. 2:1995;28-30.
39. Lobo R.A. Effects of hormone replacement on lipids and lipoproteins in postmenopausal women. J. Clin. Endocrin. Metab. 73:1991;925-930.
40. Notelovitz M., Gudat J.C., Ware M.W. Lipids and lipoproteins in women after oophorectomy and the response to oestrogen therapy. Br. J. Obstet. Gynaecol. 90:1983;171-179.
41. Mück A.O., Seeger H., Korte K., Lippert T.H. The effect of 17β-estradiol and endothelin 1 on prostacyclin and thromboxane production in human endothelial cell cultures. Clin. Exp. Obstet. Gynecol. 20:1993;203-206.